News & Articles

Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics

This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2

Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year

The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments

The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years

Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Precision dosing of the liquid therapy is very important as it must correspond to each patient’s addiction level

These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries

Working with the UK government, first vaccinations are to begin early in the new year

Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months

Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein

Explore ways to improve time to result in critical pathways such as sepsis

HALIX to provide large-scale GMP manufacture of AZD1222

In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.

Two different dosing regimens demonstrated efficacy with one showing a better profile

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported